Solara Active Pharma Sciences Stock Screener | Share Price & Fundamental Analysis
SOLARA
Pharmaceuticals
Share Price NSE
₹471.50
▼
-6.90 (-1.44%)
Share Price BSE
₹472.10
▼
-6.05 (-1.27%)
Track Solara Active Pharma Sciences share price live with TickJournal's free stock screener.
Analyze Solara Active Pharma Sciences share price history trends and compare 52-week high low
levels.
Calculate SOLARA stock fair value using fundamental analysis and view live share price charts.
Determine Solara Active Pharma Sciences share intrinsic value and compare it with current SOLARA share price.
Record your Solara Active Pharma Sciences trades in TickJournal's free trading journal and track your portfolio performance.
Solara Active Pharma Sciences Market Cap
₹1,807.12 Cr.
SOLARA P/E Ratio (TTM)
-90.93
EPS (TTM)
₹0.14
Dividend Yield
-
Debt to Equity
0.89
SOLARA 52 Week High
₹697.00
Solara Active Pharma Sciences 52 Week Low
₹450.30
Operating Margin
9.00%
Profit Margin
-4.87%
SOLARA Revenue (TTM)
₹349.00
EBITDA
₹31.00
Net Income
₹-17.00
Total Assets
₹2,232.00
Total Equity
₹1,097.00
Solara Active Pharma Sciences Share Price History - Stock Screener Chart
Screen SOLARA historical share price movements with interactive charts. Analyze price trends and patterns.
Solara Active Pharma Sciences Company Profile - Fundamental Screener
Screen Solara Active Pharma Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SOLARA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE624Z01016
Solara Active Pharma Sciences Balance Sheet Screener
Screen SOLARA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Assets | 729 | 801 | 1,188 | 1,239 | 1,058 | 672 | 648 | 608 |
| Fixed Assets | 1,193 | 1,268 | 1,364 | 1,356 | 1,382 | 1,397 | 1,218 | 1,086 |
| Liabilities | ||||||||
| Total Liabilities | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Liabilities | 191 | 172 | 296 | 354 | 232 | 333 | 344 | 315 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,097 | 937 | 1,502 | 1,527 | 1,593 | 1,090 | 960 | 769 |
| Share Capital | 40 | 36 | 36 | 36 | 36 | 27 | 26 | 25 |
| Reserves & Surplus | 1,054 | 898 | 1,464 | 1,489 | 1,553 | 963 | 826 | 739 |
Solara Active Pharma Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Solara Active Pharma Sciences income statement and profit fundamentals.
Analyze SOLARA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Solara Active Pharma Sciences share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 349 | 314 | 320 | 279 | 302 | 347 | 364 | 301 | 385 | 354 | 426 | 212 | 367 | 337 | 342 |
| Expenses | 318 | 279 | 262 | 228 | 243 | 286 | 322 | 412 | 332 | 333 | 393 | 436 | 349 | 318 | 311 |
| EBITDA | 31 | 35 | 58 | 51 | 59 | 62 | 43 | -111 | 53 | 21 | 34 | -224 | 18 | 20 | 31 |
| Operating Profit % | 9.00% | 11.00% | 18.00% | 17.00% | 19.00% | 18.00% | 12.00% | -38.00% | 13.00% | 5.00% | 8.00% | -106.00% | 3.00% | 4.00% | 8.00% |
| Depreciation | 26 | 25 | 24 | 24 | 25 | 25 | 25 | 25 | 27 | 26 | 26 | 26 | 28 | 28 | 29 |
| Interest | 23 | 21 | 24 | 29 | 27 | 28 | 31 | 31 | 22 | 25 | 24 | 25 | 22 | 23 | 22 |
| Profit Before Tax | -17 | -10 | 11 | -2 | 8 | 8 | -14 | -167 | 5 | -29 | -17 | -275 | -31 | -31 | -19 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89 | 1 | -10 | 0 | 0 | -33 | -15 | -9 |
| Net Profit | -17 | -10 | 11 | -2 | 8 | 8 | -14 | -255 | 4 | -19 | -17 | -275 | 2 | -17 | -10 |
| EPS | -3.98 | -2.36 | 2.46 | -0.93 | 2.03 | 2.54 | -3.50 | -70.93 | 1.05 | -5.43 | -4.77 | -72.07 | 0.53 | -4.56 | -2.77 |
Solara Active Pharma Sciences Cash Flow Screener - Liquidity Fundamentals
Screen SOLARA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 213 | 109 | 156 | -242 | 156 | 242 | 166 | 49 |
| Investing Activities | -37 | -4 | -81 | -243 | -106 | -359 | -113 | -86 |
| Financing Activities | -181 | -106 | -113 | 334 | 93 | 97 | -23 | 68 |
| Net Cash Flow | -5 | 0 | -38 | -151 | 142 | -20 | 30 | 32 |
Solara Active Pharma Sciences Shareholding Pattern Screener
See Solara Active Pharma Sciences shareholding pattern with promoter, FII, and DII holdings.
Check Solara Active Pharma Sciences promoter holding and ownership changes for SOLARA on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 42.00% | 42.01% | 42.01% | 37.94% | 37.23% | 37.27% | 37.27% | 30.49% |
| FII Holding | 11.98% | 13.58% | 14.25% | 14.63% | 14.67% | 14.25% | 14.00% | 15.80% |
| DII Holding | 3.64% | 2.69% | 2.62% | 2.61% | 3.19% | 3.38% | 2.83% | 2.97% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.63% | 24.01% | 23.47% | 23.07% | 21.93% | 18.83% | 19.61% | 20.15% |
| Other Holding | 17.74% | 17.70% | 17.63% | 21.74% | 22.98% | 26.28% | 26.29% | 30.59% |
| Shareholder Count | 71,920 | 72,479 | 74,334 | 75,791 | 83,148 | 71,882 | 78,617 | 73,912 |
Solara Active Pharma Sciences Share Dividend Screener - Share Yield Analysis
Check Solara Active Pharma Sciences dividend history with payout and yield data.
View Solara Active Pharma Sciences dividend details including ex-dates and amounts for SOLARA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹3.00 | 0.88% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹7.00 | 1.14% |
| 2020-March | ₹2.00 | 0.16% |
| 2019-March | ₹5.00 | 1.22% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Solara Active Pharma Sciences Stock Index Membership
See which indices include Solara Active Pharma Sciences stock.
Check SOLARA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Solara Active Pharma Sciences Market Events Screener - Corporate Actions
Get Solara Active Pharma Sciences corporate actions including splits, bonuses, and buybacks.
Check Solara Active Pharma Sciences stock events that may affect SOLARA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 6.04% | ||
| Annual General Meeting | NA | 1.93% | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 3.68% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 4.92% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -5.12% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 19.48% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 3.97% |
| 2024-10-21 | 2024-10-21 | Quarterly Result Announcement | NA | 8.11% |
| 2024-05-15 | 2024-05-15 | Rights | 1:3 | 8.26% |
| 2021-08-18 | 2021-08-20 | Dividend | ₹ 3.00 /share | 5.36% |
| 2017-03-25 | 2017-03-25 | Change Of Name | NA | - |
Solara Active Pharma Sciences Competitors Screener - Peer Comparison
Screen SOLARA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
Solara Active Pharma Sciences Company Announcements - News Screener
Screen SOLARA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025. | View |
| 2026-02-13 | Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies. | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-13 | Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025 | View |
| 2026-02-13 | Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025 | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-04 | Dispatch Of Second Reminder Notice For Payment Of First Call Money | View |
| 2026-02-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-30 | Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025. | View |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-24 | Closure of Trading Window | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-12-17 | Reconstitution Of The Management Committee | View |